Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis

por Wijsenbeek, Marlies S., Grutters, Jan C., Wuyts, Wim A.
Publicado 2015

Patients’ and healthcare professionals’ perspectives on the idiopathic pulmonary fibrosis care journey: a qualitative study

por Delameillieure, Anouk, Dobbels, Fabienne, Vandekerkhof, Sarah, Wuyts, Wim A.
Publicado 2021

Electronically monitored medication adherence in idiopathic pulmonary fibrosis: prevalence, predictors and outcomes

por Delameillieure, Anouk, Wuyts, Wim A., Pironet, Antoine, Dobbels, Fabienne
Publicado 2022

Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models

por Wuyts, Wim A., Peccatori, Fedro A., Russell, Anne-Marie
Publicado 2014

Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage

por De Sadeleer, Laurens J., Goos, Tinne, Yserbyt, Jonas, Wuyts, Wim A.
Publicado 2020

Mechanic’s hands in a woman with undifferentiated connective tissue disease and interstitial lung disease – anti-PL7 positive antisynthetase syndrome: a case report

por De Langhe, Ellen, Lenaerts, Jan, Bossuyt, Xavier, Westhovens, Rene, Wuyts, Wim A
Publicado 2015

Care programs and their components for patients with idiopathic pulmonary fibrosis: a systematic review

por Delameillieure, Anouk, Vandekerkhof, Sarah, Van Grootven, Bastiaan, Wuyts, Wim A., Dobbels, Fabienne
Publicado 2021

Clinical use of biomarkers of survival in pulmonary fibrosis

por Thomeer, Michiel, Grutters, Jan C, Wuyts, Wim A, Willems, Stijn, Demedts, Maurits G
Publicado 2010

First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value

por Wuyts, Wim A., Kolb, Martin, Stowasser, Susanne, Stansen, Wibke, Huggins, John T., Raghu, Ganesh
Publicado 2016

Behavioural and psychological patterns of patients with idiopathic pulmonary fibrosis: a prospective study

por Delameillieure, Anouk, Dobbels, Fabienne, Fieuws, Steffen, Leceuvre, Katleen, Vanderauwera, Sara, Wuyts, Wim A.
Publicado 2022

Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?

por Wuyts, Wim A., Cavazza, Alberto, Rossi, Giulio, Bonella, Francesco, Sverzellati, Nicola, Spagnolo, Paolo
Publicado 2014

Are genes the missing link to detect and prognosticate RA-ILD?

por Vermant, Marie, Goos, Tinne, Gogaert, Stefan, De Cock, Diederik, Verschueren, Patrick, Wuyts, Wim A
Publicado 2023

Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series

por Delanote, Isabelle, Wuyts, Wim A., Yserbyt, Jonas, Verbeken, Eric K., Verleden, Geert M., Vos, Robin
Publicado 2016

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management

por van Cleemput, Johan, Sonaglioni, Andrea, Wuyts, Wim A., Bengus, Monica, Stauffer, John L., Harari, Sergio
Publicado 2018

Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis

por McDonough, John E, Kaminski, Naftali, Thienpont, Bernard, Hogg, James C, Vanaudenaerde, Bart M, Wuyts, Wim A
Publicado 2019

Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis

por Richeldi, Luca, Kolb, Martin, Jouneau, Stéphane, Wuyts, Wim A., Schinzel, Birgit, Stowasser, Susanne, Quaresma, Manuel, Raghu, Ganesh
Publicado 2020

Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?

por Wijsenbeek, Marlies S., Bonella, Francesco, Orsatti, Leticia, Russell, Anne-Marie, Valenzuela, Claudia, Wuyts, Wim A., Baile, Walter F.
Publicado 2022

The 6-min walk test as a primary end-point in interstitial lung disease

por Harari, Sergio, Wells, Athol U., Wuyts, Wim A., Nathan, Steven D., Kirchgaessler, Klaus-Uwe, Bengus, Monica, Behr, Jürgen
Publicado 2022

Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be

por Goos, Tinne, De Sadeleer, Laurens J., Yserbyt, Jonas, Verleden, Geert M., Vermant, Marie, Verleden, Stijn E., Wuyts, Wim A.
Publicado 2021

Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review

por Bos, Saskia, De Sadeleer, Laurens J., Vanstapel, Arno, Beeckmans, Hanne, Sacreas, Annelore, Yserbyt, Jonas, Wuyts, Wim A., Vos, Robin
Publicado 2021